Earnings Feed
Start Free
LIXTE BIOTECHNOLOGY HOLDINGS, INC.·4

Dec 11, 9:15 PM ET

Schwartzberg Gil 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Dec 11, 2018

Insider Transaction Report

Form 4
Period: 2018-12-07
LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT.OB
Schwartzberg Gil
10% Owner
Transactions
  • Other

    Common Stock

    2018-12-07+150,000→ 2,045,068 total
  • Gift

    Warrants to Purchase Common Stock

    2018-12-07−1,040,000→ 0 total
    Exercise: $1.00From: 2018-12-07Exp: 2022-11-30→ Common Stock (1,040,000 underlying)
  • Gift

    Common Stock

    2018-12-07−600,000→ 1,066,356 total(indirect: By Trust)
  • Purchase

    Common Stock

    2018-12-07$0.50/sh+1,040,000$520,000→ 1,895,068 total
  • Purchase

    Warrants to Purchase Common Stock

    2018-12-07$0.50/sh+1,040,000$520,000→ 1,540,000 total
    Exercise: $1.00From: 2018-12-07Exp: 2022-11-30→ Common Stock (1,040,000 underlying)
Holdings

  • Common Stock

    (indirect: By Continuum Partners, L.P.)
    63,811
Footnotes (3)
  • [F1]The reporting person acquired 1,040,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50.
  • [F2]Represents shares acquired by the reporting person pursuant to enforcement of a judgment.
  • [F3]Represents the reporting person's proportionate interest in Continuum Partners, L.P. which owns 638,115 shares of the issuer's common stock.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT